155 related articles for article (PubMed ID: 18242021)
1. Solid-state characterization of an NR2B selective N-methyl d-aspartate (NMDA) antagonist polymorphs.
Kojima T; Sato M; Omura A; Kawai M; Sakai M; Matsuoka Y; Murata Y; Hattori K; Sakemi S; Bordner J; Samardjiev I; Mano T
Int J Pharm; 2008 May; 355(1-2):337-40. PubMed ID: 18242021
[TBL] [Abstract][Full Text] [Related]
2. Discovery of (-)-6-[2-[4-(3-fluorophenyl)-4-hydroxy-1-piperidinyl]-1-hydroxyethyl]-3,4-dihydro-2(1H)-quinolinone--a potent NR2B-selective N-methyl D-aspartate (NMDA) antagonist for the treatment of pain.
Kawai M; Ando K; Matsumoto Y; Sakurada I; Hirota M; Nakamura H; Ohta A; Sudo M; Hattori K; Takashima T; Hizue M; Watanabe S; Fujita I; Mizutani M; Kawamura M
Bioorg Med Chem Lett; 2007 Oct; 17(20):5558-62. PubMed ID: 17766106
[TBL] [Abstract][Full Text] [Related]
3. Synergy between a NR2B receptor antagonist DHQ and 3-methyl-gabapentin in mice with neuropathic pain.
Imai A; Hizue M; Toide K
Eur J Pharmacol; 2008 Jul; 588(2-3):244-7. PubMed ID: 18511033
[TBL] [Abstract][Full Text] [Related]
4. Crystal forms of atorvastatin.
An SG; Sohn YT
Arch Pharm Res; 2009 Jun; 32(6):933-6. PubMed ID: 19557372
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of a novel polymorph of indiplon, Form α.
Xu L; Wang J; Xiao B; Yang J; Liu Y; Huang R
Bioorg Med Chem Lett; 2012 Jan; 22(2):963-8. PubMed ID: 22209207
[TBL] [Abstract][Full Text] [Related]
6. Three polymorphic forms of the co-crystal 4,4'-bipyridine/pimelic acid and their structural, thermal, and spectroscopic characterization.
Braga D; Palladino G; Polito M; Rubini K; Grepioni F; Chierotti MR; Gobetto R
Chemistry; 2008; 14(32):10149-59. PubMed ID: 18803188
[TBL] [Abstract][Full Text] [Related]
7. Long-term potentiation in the nucleus accumbens requires both NR2A- and NR2B-containing N-methyl-D-aspartate receptors.
Schotanus SM; Chergui K
Eur J Neurosci; 2008 Apr; 27(8):1957-64. PubMed ID: 18412616
[TBL] [Abstract][Full Text] [Related]
8. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors.
Mony L; Krzaczkowski L; Leonetti M; Le Goff A; Alarcon K; Neyton J; Bertrand HO; Acher F; Paoletti P
Mol Pharmacol; 2009 Jan; 75(1):60-74. PubMed ID: 18923063
[TBL] [Abstract][Full Text] [Related]
9. Conformational analysis and crystal structure of {[1-(3-chloro-4-fluorobenzoyl)-4-fluoropiperidin-4yl]methyl}[(5-methylpyridin-2-yl)methyl]amine, fumaric acid salt.
Ribet JP; Pena R; Maurel JL; Belin C; Tillard M; Vacher B; Bonnaud B; Colpaert F
Spectrochim Acta A Mol Biomol Spectrosc; 2005 Nov; 62(1-3):353-63. PubMed ID: 16257736
[TBL] [Abstract][Full Text] [Related]
10. Late phase of long-term potentiation induced by co-application of N-methyl-d-aspartic acid and the antagonist of NR2B-containing N-methyl-d-aspartic acid receptors in rat hippocampus.
Oh-Nishi A; Saji M; Satoh SZ; Ogata M; Suzuki N
Neuroscience; 2009 Mar; 159(1):127-35. PubMed ID: 19010396
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of a new polymorphic form and a solvate of glibenclamide.
Hassan MA; Sheikh Salem M; Sallam E; al-Hindawi MK
Acta Pharm Hung; 1997; 67(2-3):81-8. PubMed ID: 9223758
[TBL] [Abstract][Full Text] [Related]
12. Reevaluation of solubility of tolbutamide and polymorphic transformation from Form I to unknown crystal form.
Hasegawa G; Komasaka T; Bando R; Yoshihashi Y; Yonemochi E; Fujii K; Uekusa H; Terada K
Int J Pharm; 2009 Mar; 369(1-2):12-8. PubMed ID: 19026732
[TBL] [Abstract][Full Text] [Related]
13. Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonists.
Nguyen KT; Claiborne CF; McCauley JA; Libby BE; Claremon DA; Bednar RA; Mosser SD; Gaul SL; Connolly TM; Condra CL; Bednar B; Stump GL; Lynch JJ; Koblan KS; Liverton NJ
Bioorg Med Chem Lett; 2007 Jul; 17(14):3997-4000. PubMed ID: 17498948
[TBL] [Abstract][Full Text] [Related]
14. Tonic facilitation of glutamate release by glycine binding sites on presynaptic NR2B-containing NMDA autoreceptors in the rat visual cortex.
Li YH; Han TZ; Meng K
Neurosci Lett; 2008 Feb; 432(3):212-6. PubMed ID: 18248890
[TBL] [Abstract][Full Text] [Related]
15. Single-crystal and powder X-ray diffraction and solid-state 13C NMR of p-nitrophenyl glycopyranosides, the derivatives of D-galactose, D-glucose, and D-mannose.
Gubica T; Temeriusz A; Paradowska K; Ostrowski A; Klimentowska P; Cyrański MK
Carbohydr Res; 2009 Sep; 344(13):1734-44. PubMed ID: 19560752
[TBL] [Abstract][Full Text] [Related]
16. Solid form selection of zwitterionic 5-HT4 receptor agonist.
Kojima T; Sugano K; Onoue S; Murase N; Sato M; Kawabata Y; Mano T
Int J Pharm; 2008 Feb; 350(1-2):35-42. PubMed ID: 17919860
[TBL] [Abstract][Full Text] [Related]
17. Single crystal and powder diffraction characterization of three polymorphic forms of Acitretin.
Malpezzi L; Magnone GA; Masciocchi N; Sironi A
J Pharm Sci; 2005 May; 94(5):1067-78. PubMed ID: 15799018
[TBL] [Abstract][Full Text] [Related]
18. Insight into the conformational polymorph transformation of a block-buster multiple sclerosis drug fingolimod hydrochloride (FTY 720).
Wang JR; Li S; Zhu B; Mei X
J Pharm Biomed Anal; 2015 May; 109():45-51. PubMed ID: 25746505
[TBL] [Abstract][Full Text] [Related]
19. Solid-state form screen of cardiosulfa and its analogues.
Kumar SS; Rana S; Nangia A
Chem Asian J; 2013 Jul; 8(7):1551-68. PubMed ID: 23616361
[TBL] [Abstract][Full Text] [Related]
20. Discovery of (R)-1-[2-hydroxy-3-(4-hydroxy-phenyl)-propyl]-4-(4-methyl-benzyl)-piperidin-4-ol: a novel NR1/2B subtype selective NMDA receptor antagonist.
Pinard E; Alanine A; Bourson A; Büttelmann B; Gill R; Heitz M; Jaeschke G; Mutel V; Trube G; Wyler R
Bioorg Med Chem Lett; 2001 Aug; 11(16):2173-6. PubMed ID: 11514163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
